Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardioangiologica 2018 February;66(1) > Minerva Cardioangiologica 2018 February;66(1):1-5

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Cardioangiologica 2018 February;66(1):1-5

DOI: 10.23736/S0026-4725.17.04500-5

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Budget impact analysis of rivaroxaban vs. warfarin anticoagulation strategy for direct current cardioversion in non-valvular atrial fibrillation patients: the MonaldiVert Economic Study

Vincenzo RUSSO 1, Anna RAGO 1, Andrea A. PAPA 1 , Valter BIANCHI 2, Vincenzo TAVOLETTA 2, Stefano DE VIVO 2, Ciro CAVALLARO 2, Gerardo NIGRO 1, Antonio D’ONOFRIO 2

 

ACCESS OPTIONS

You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of  € 45,00.

Downloading and printing for personal use allowed.

Regain access


Access as an individual subscriber


Access through your institution

Subscribe to Minerva Cardiology and Angiology


Recommend to your librarian

top of page